CD4+ T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment

Journal of Virology

Volumn 74, Issue 8, 2000, Pages 3455-3463

  Plotnicky Gilquin, Hélène ^a   Robert, Alain ^a   Chevalet, Laurent ^a   Haeuw, Jean Francois ^a   Beck, Alain ^a   Bonnefoy, Jean Yves ^a   Brandt, Christian ^b   Siegrist, Claire Anne ^b   Nguyen, Thien Ngoc ^a   Power, Ultan F ^a  

^a Centre d'Immunologie Pierre Fabre   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HYBRID PROTEIN; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS PROTEIN;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; FEMALE; HELPER CELL; IMMUNIZATION; MOUSE; NONHUMAN; PASSIVE IMMUNIZATION; PRIORITY JOURNAL; RAT; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SCID MOUSE; SUPPRESSOR CELL; UPPER RESPIRATORY TRACT INFECTION;

ADOPTIVE TRANSFER; ANIMALS; B-LYMPHOCYTES; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; HN PROTEIN; IMMUNITY, MATERNALLY-ACQUIRED; IMMUNIZATION; MICE; MICE, INBRED BALB C; MICE, SCID; PREGNANCY; RECOMBINANT FUSION PROTEINS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUSES; RESPIRATORY TRACT INFECTIONS; T-LYMPHOCYTES; VIRAL ENVELOPE PROTEINS; VIRAL PROTEINS;

EID: 0034030608     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.8.3455-3463.2000     Document Type: Article

References (53)

1. Alwan, W. H., W. J. Kozlowska, and P. J. M. Openshaw. 1994. Distinct types of lung disease caused by functional subsets of antiviral T cells. J. Exp. Med. 179:81-89.
2. Alwan, W. H., F. M. Record, and P. J. Openshaw. 1992. CD4+ T cells clear virus hut augment disease in mice infected with respiratory syncytial virus. Comparison with the effects of CD8+ T cells. Clin. Exp. Immunol. 88:527-536.
3. Asanuma, H., A. H. Thompson, T. Iwasaki, Y. Sato, Y. Inaba, C. Aizawa, T. Kurata, and S.-I. Tamura. 1997. Isolation and characterization of mouse nasal-associated lymphoid tissue. J. Immunol. Methods 202:123-131.
4. Bansal, G. P., J. Hatfield, J. F. Young, et al. 1991. Efficacy of passively administered monoclonal antibodies against respiratory syncytial virus infection in cotton rats, p. 283-8. In R. M. Chanock, H. S. Ginsberg, F. Brown, and R. A. Lerner (ed.), Vaccines - 1991. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
5. Brandt, C., U. F. Power, H. Plotnicky-Gilquin, T. Huss, T. N. Nguyen, P. H. Lambert, H. Binz, and C. A. Siegrist. 1997. Protective immunity against respiratory syncytial virus in early life after murine maternal or neonatal vaccination with the recombinant G fusion protein BBG2Na. J. Infect. Dis. 176:884-891.
6. Bukowski, J. F., C. T. Morita, and M. B. Brenner. 1994. Recognition and destruction of virus-infected cells by human gamma delta CTL. J. Immunol. 153:5133-5140.
7. Cannon, M. J., E. J. Stott, G. Taylor, and B. A. Askonas. 1987. Clearance of persistent respiratory syncytial virus infections in immunodeficient mice following transfer of primed T cells. Immunol. 62:133-138.
8. Carding, S. R., W. Allan, S. Kyes, A. Hayday, K. Bottomly, and P. C. Doherty. 1990. Late dominances of the inflammatory process in murine influenza by gamma-delta+ T cells. J. Exp. Med. 172:1225-1231.
9. Collins, P. L., K. McIntosh, and R. M. Chanock. Respiratory syncytial virus, p. 1313-1351. In B. N. Fields, D. N. Knipe, and P. M. Howley (ed.), Virology - 1996. Lippincott-Raven, Philadelphia, Pa.
10. Connors, M., P. L. Collins, C. Y. Firestone, and B. R. Murphy. 1991. Respiratory syncytial virus (RSV) F, G, M2 (22K), and N proteins each induce resistance to RSV challenge, but resistance induced by M2 and N proteins is relatively short-lived. J. Virol. 65:1634-1637.
11. Corvaia, N., P. Tournier, T. N. Nguyen, J. F. Haeuw, U. F. Power, H. Binz, and C. Andreoni. 1997. Challenge of BALB/c mice with respiratory syncytial virus does not enhance the Th2 pathway induced after immunization with a recombinant G fusion protein, BBG2Na, in aluminum hydroxide. J. Infect. Dis. 176:560-569.
12. Eichelberger, M., W. Allan, M. Zijlstra, R. Jaenisch, and P. C. Doherty. 1991. Clearance of influenza virus respiratory infection in mice lacking class I major histocompatibility complex-restricted CD8+ T cells. J. Exp. Med. 174:875-880.
13. Graham, B. S., L. A. Bunton, P. F. Wright, and D. T. Karzon. 1991. The role of T cell subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice. J. Clin. Investig. 88:1026-1033.
14. Graham, B. S., L. A. Bunton, P. F. Wright, and D. T. Karzon. 1991. Respiratory syncytial virus in anti-μ-treated mice. J. Virol. 65:4936-4942.
15. Haanen, J. B. A. G., M. Toebes, T. A. Cordaro, M. C. Wolkers, A. M. Kruisbeek, and T. N. M. Schuman. 1999. Systemic T cell expension during localized viral infection. Eur. J. Immunol. 29:1168-1174.
16. Hall, C. B., K. R. Powell, N. E. MacDonald, C. L. Gala, M. E. Menegus, S. C. Suffin, and H. J. Cohen. 1986. Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 315:77-81.
17. Hancock, G. E., D. J. Speelman, K. Heers, E. Bortell, J. Smith, and C. Cosco. 1996. Generation of atypical pulmonary inflammatory responses in BALB/c mice after immunization with the native attachment (G) glycoprotein of respiratory syncytial virus. J. Virol. 70:7783-7791.
18. Hemming, V. G., G. A. Prince, W. T. London, P. A. Baron, R. Brown, and R. M. Chanock. 1988. Topically administered immunoglobulin reduces pulmonary respiratory syncytial virus shedding in owl monkeys. Antimicrob. Agents Chemother. 32:1269-1270.
19. Herzenberg, L. A., A. M. Stall, P. A. Lalor, C. Sidman, W. A. Moore, D. R. Parks, and L. A. Herzenberg. 1986. The LY-1 B lineage. Immunol. Rev. 93:81-102.
20. Hou, S., P. C. Doherty, M. Zijlstra, R. Jaenisch, and J. M. Katz. 1992. Delayed clearance of Sendai virus in mice lacking class I MHC-restricted CD8+ T cells. J. Immunol. 149:1319-1325.
21. Johnson, P. R., and P. L. Collins. 1988. The fusion glycoproteins of human respiratory syncytial virus of subgroups A and B: sequence conservation provides a structural basis for antigenic relatedness. J. Gen. Virol. 69:2623-2628.
22. Koornastra, P. J., F. I. C. R. S. De Jong, L. M. K. Vlek, E. H. M. A. Marres, and P. J. C. Van Breda Vriesman. 1991. The Waldeyer ring equivalent in the rat. Acta Otolaryngol. (Stockholm) 111:591-595.
23. Kuper, C. F., P. J. Koornastra, D. M. H. Hameleers, J. Biewenga, B. J. Spit, A. M. Duijvestijn, P. J. C. Van Breda Vriesman, and T. Sminnia. 1992. The role of nasopharyngeal lymphoid tissue. Immunol. Today 13:219-224.
24. R3 and autogenous negative control by repressor. J. Mol. Biol. 139:147-161.
25. Mazanec, M. B., M. E. Lamm, D. Lyn, A. Portner, and J. G. Nedrud. 1992. Comparison of IgA versus IgG monoclonal antibodies for passive immunization of the murine respiratory tract. Virus Res. 23:1-12.
26. McIntosh, K., H. B. Masters, I. Orr, R. K. Chao, and R. M. Barkin, 1978. The immunologic response to infection with respiratory syncytial virus in infants. J. Infect. Dis. 138:24-32.
27. Mills, J. V., J. A. Van Kirk, P. F. Wright, and R. M. Chanock. 1971. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J. Immunol. 107:123-130.
28. Murby, M., E. Samuelsson, T. N. Nguyen, L. Mignard, U. Power, H. Binz, M. Uhlen, and S. Stahl. 1995. Hydrophobicity engineering to increase solubility and stability of a recombinant protein from respiratory syncytial virus. Eur. J. Biochem. 230:38-44.
29. Neuzil, K. M., Y. W. Tang, and B. S. Graham. 1996. Protective role of TNF alpha in respiratory syncytial virus infection in vitro and in vivo. Am. J. Med. Sci. 311:201-204.
30. Nguyen, T. N., M. H. Gourdon, M. Hansson, A. Robert, P. Samuelson, C. Libon, C. Andreoni, P. A. Nygren, H. Binz, and M. Uhlen. 1995. Hydrophobicity engineering to facilitate surface display of heterologous gene products in Staphylococcus xylosus. J. Biotechnol. 42:207-219.
31. Olmsted, R. A., N. Elango, G. A. Prince, B. R. Murphy, P. R. Johnson, B. Moss, R. M. Chanock, and P. L. Collins. 1986. Expression of the F glycoprotein of respiratory syncytial virus by a recombinant vaccinia virus: comparison of the individual contributions of the F and G glycoproteins to host immunity. Proc. Natl. Acad. Sci. USA 83:7462-7466.
32. d-restricted cytotoxic T lymphocytes from mice primed by infection. J. Virol. 64:1683-1689.
33. Pemberton, R. M., M. J. Cannon, P. J. M. Openshaw, L. A. Ball, G. A. Wertz, and B. A. Askonas. 1987. Cytotoxic T-cell specificity for respiratory syncytial virus proteins: fusion protein is an important target antigen. J. Gen. Virol. 68:2177-2182.
34. Piazza, F. M., S. A. Johnson, M. G. Ottolini, H. J. Schmidt, M. E. Darnell, V. G. Hemming, and G. A. Prince. 1992. Immunotherapy of respiratory syncytial virus infection in cotton rats (Sigmodon fulviventer) using IgG in a small-particle aerosol. J. Infect. Dis. 166:1422-1424.
35. Plotnicky-Gilquin, H., L. Goetsch, T. Huss, T. Champion, A. Beck, J.-F. Haeuw, T. N. Nguyen, J.-Y. Bonnefoy, N. Corvaïa, and U. F. Power. 1999. Identification of multiple protective epitopes (protectopes) in the central conserved domain of a prototype human respiratory syncytial virus G protein. J. Virol. 73:5637-5645.
36. Plotnicky-Gilquin, H., T. Huss, J.-P. Aubry, J.-F. Haeuw, A. Beck, J.-Y. Bonnefoy, T. N. Nguyen, and U. F. Power. 1999. Absence of lung immunopathology following respiratory syncytial virus (RSV) challenge in mice immunized with a recombinant RSV G protein fragment. Virology 258:128-140.
37. Power, U. F., H. Plotnicky-Gilquin, T. Huss, A. Robert, M. Trudel, S. Stahl, M. Uhlen, T. N. Nguyen, and H. Binz. 1997. Induction of protective immunity in rodents by vaccination with a prokaryotically expressed recombinant fusion protein containing a respiratory syncytial virus G protein fragment. Virology 230:155-166.
38. Ramsay, A. J., J. Ruby, and I. A. Ramshaw. 1993. The case for cytokines as effector molecules in the resolution of virus infections. Immunol. Today 14:155-157.
39. Renegar, K. B., and P. A. Small, Jr. 1991. Passive transfer of local immunity to influenza virus infection by IgA antibody. J. Immunol. 146:1972-1978.
40. Routledge, E. G., M. M. Willcocks, A. C. R. Samson, L. Morgan, R. Scott, J. J. Anderson, and G. L. Toms. 1988. The purification of four respiratory syncytial virus proteins as protective agents against experimental infection in BALB/c mice. J. Gen. Virol. 69:293-303.
41. Sparer, T. E., S. Matthews, T. Hussell, A. J. Rae, B. Garcia-Barreno, J. A. Malero, and P. J. Openshaw. 1998. Eliminating a region of respiratory syncytial virus attachment protein allows induction of protective immunity without vaccine-enhanced lung eosinophilia. J. Exp. Med. 187:1921-1926.
42. Srikiatkhachorn, A., W. Chang, and T. J. Braciale. 1999. Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent. J. Virol. 73: 6590-6597.
43. Ståhl, S., A. Sjölander, P.-Å. Nygren, K. Berzins, P. Perlmann, and M. Uhlén. 1989. A dual expression system for the generation, analysis and purification of antibodies to a repeated sequence of the Plasmodium falciparum antigen Pf155/RESA. J. Immunol. Methods 124:43-52.
44. Stott, E. J., and G. Taylor. 1985. Respiratory syncytial virus, brief review. Arch. Virol. 84:1-52.
45. Stott, E. J., G. Taylor, L. A. Ball, K. K.-Y. Young, A. M. Q. King, and G. W. Wertz. 1987. Immune and histopathological responses in animals vaccinated with recombinant vaccinia viruses that express individual genes of human respiratory syncytial virus. J. Virol. 61:3855-3861.
46. Taylor, G., E. J. Stott, M. Bew, B. F. Fernie, P. J. Cote, A. P. Collins, M. Hughes, and J. Jebbett. 1984. Monoclonal antibodies protect against respiratory syncytial virus infection in mice. Immunology 52:137-142.
47. Tebbey, P. W., M. Hagen, and G. E. Hancock. 1998. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus. J. Exp. Med. 188:1967-1972.
48. Trudel, M., F. Nadon, C. Seguin, and H. Binz. 1991. Protection of BALB/c mice from respiratory syncytial virus infection by immunization with a synthetic peptide derived from the G glycoprotein. Virology 185:749-757.
49. Wagner, D. K., P. Muelenaer, F. W. Henderson, M. H. Snyder, C. B. Reimer, E. E. Walsh, L. J. Anderson, D. L. Nelson, and B. R. Murphy. 1989. Serum immunoglobulin G antibody subclass response to respiratory syncytial virus F and G glycoproteins after first, second and third infection. J. Clin. Microbiol. 27:589-592.
50. Walsh, E. E., C. B. Hall, M. Briselli, M. W. Brandriss, and J. J. Schlesinger. 1987. Immunization with glycoprotein subunits of respiratory syncytial virus protect cotton rats against viral infection. J. Infect. Dis. 155:1198-1204.
51. Walsh, E. E., J. J. Schlesinger, and M. W. Brandriss. 1984. Protection from respiratory syncytial virus infection in cotton rats by passive transfer of monoclonal antibodies. Infect. Immun. 43:756-758.
52. Watt, P. J., B. S. Robinson, C. R. Pringle, and D. A. Tyrell. 1990. Determinants of susceptibility to challenge and the antibody response in adults volunteers given experimental respiratory syncytial virus vaccines. Vaccine 8:231-236.
53. Wu, H.-Y., E. B. Nikolova, K. W. Beagley, and M. W. Russel. 1996. Induction of antibody-secreting cells and T-helper and memory cells in murine nasal lymphoid tissue. Immunology 88:493-500.